Latest Financial Results
Q3 2022

Latest Annual Filing
For Fiscal Year Ending Dec 31, 2021
Report Links
Email Alerts
Sign up today and receive company updates straight to your inbox.

Company Overview
Avenue Therapeutics is a specialty pharmaceutical company whose mission is to develop IV tramadol, a potential alternative that could reduce the use of conventional opioids, for patients suffering from acute pain in the U.S. Avenue is headquartered in New York City and was founded by Fortress Biotech, Inc.
Stock Information
IR Contacts
Headquarters
Avenue Therapeutics, Inc.
2 Gansevoort Street
9th Floor
New York, NY 10014
Investor Relations
Jaclyn Jaffe and Bill Begien
T: 781-652-4500
ir@avenuetx.com
Transfer Agent
VStock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
T: 212-828-8436
info@vstocktransfer.com
https://www.vstocktransfer.com